"We will be carefully monitoring the recruitment of patients in this trial, and report progress as we go".
And so danger I alluded to yesterday is revealed. If the first report is anywhere near what we expect, this will have a 1 in front of it before you can blink.
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-3
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
81.0¢ |
Change
0.035(4.52%) |
Mkt cap ! $100.1M | |||
| Open | High | Low | Value | Volume |
| 80.5¢ | 82.0¢ | 79.0¢ | $50.59K | 62.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9441 | 79.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 81.0¢ | 961 | 1 |
View Market Depth
| Last trade - 15.52pm 26/07/2024 (20 minute delay) ? |
| AGN (ASX) Chart |